SC
Silverstein Christine Berni
Director
BoardF
Insider track record
Board DirectorAcross 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the complete record of transactions filed by Silverstein Christine Berni, Director. Officer active across 2 companies, notably Abeona Therapeutics INC.. In total, 14 disclosures have been recorded. Breakdown: 0 buy · 2 sells. Total volume traded: €132k. Activity tracked since 25 May 2021. The latest transaction was disclosed on 26 January 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations14 total
37,313 shares0Common StockSEC:0001493152-26-003807:0
9,398 shares@ US$0.55100.0% of flowCommon StockSEC:0001104659-25-011238:0
36,101 shares0Common StockSEC:0001493152-25-004752:0
11,797 shares0Common StockSEC:0001493152-24-034056:0
23,611 shares0Common StockSEC:0001493152-24-026647:0
25,821 shares@ US$4.5128.4% of flowCommon StockSEC:0001493152-24-024527:0
2,300 shares0Common StockSEC:0001415889-24-017643:0
4,600 shares0Common StockSEC:0001415889-24-001602:0
6,330 shares@ US$3.90548.6% of flowCommon StockSEC:0001493152-23-034858:0
58,689 shares@ US$4.6265.5% of flowCommon StockSEC:0001493152-23-021648:0
7,200 shares0Common StockSEC:0001415889-23-001546:0
13,400 shares0Common StockSEC:0001493152-22-027051:0
38,590 shares0Common StockSEC:0001493152-21-013121:0
38,590 shares0Common StockSEC:0001493152-21-013121
About Silverstein Christine Berni
Christine Berni Silverstein is a Director at Abeona Therapeutics Inc. In this role, she participates in strategic decision-making and overseeing the company's operations. Her expertise in the biopharmaceutical sector is an asset for Abeona.